Related Experiment Video
Updated: Mar 17, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
Liver Failure due to Acute Viral Hepatitis (A-E)
Paul Manka1, Jens Verheyen2, Guido Gerken3
1Department of Gastroenterology and Hepatology, University Hospital Essen, Essen, Germany; Regeneration and Repair Group, The Institute of Hepatology, Foundation for Liver Research, London, UK; Division of Transplantation Immunology and Mucosal Biology, King's College, London, UK.
Viral hepatitis remains a major cause of acute liver failure (ALF). While liver transplantation was once the primary treatment, nucleotide analogs now effectively manage hepatitis B virus (HBV)-induced ALF.
Area of Science:
- Hepatology
- Virology
- Gastroenterology
Background:
- Viral hepatitis is a significant global cause of acute liver failure (ALF).
- Hepatitis A, B, and E are primary viral culprits, with increasing autochthonous hepatitis E infections in Europe.
- Reactivation of hepatitis B virus (HBV) in immunosuppressed patients is a growing concern.
Purpose of the Study:
- To provide an overview of acute liver failure (ALF) caused by viral hepatitis.
- To examine the epidemiology, clinical course, and treatment strategies for viral hepatitis-induced ALF.
- To highlight current trends and therapeutic advancements in managing viral hepatitis-related liver failure.
Main Methods:
- A comprehensive literature search of the PubMed database was performed.
- Inclusion criteria encompassed recent studies, reviews, meta-analyses, and clinical guidelines.
- The search focused on viral hepatitis as an etiology of ALF, covering epidemiology, disease progression, and treatment.
Main Results:
- Hepatitis A, B, and B/D infections are most frequently associated with fulminant courses, unlike hepatitis C.
- Hepatitis E causes ALF and is increasingly observed in Europe, even in non-endemic areas.
- Nucleotide/nucleoside analog treatment for HBV-induced ALF shows positive outcomes, offering an alternative to liver transplantation.
Conclusions:
- Despite declining numbers in Western Europe, etiological diagnosis through screening for hepatitis A-E is crucial.
- Identifying patients at high risk for developing ALF from viral hepatitis is essential for timely intervention.
- Effective management strategies, including antiviral therapy for HBV, are improving outcomes for viral hepatitis-induced ALF.
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute Kidney Injury III: Clinical Manifestations

